Introduction
Dietary factors play an important role in the tumorigenesis of colonic tissue at both the level of initiation as well as progression (1EE4). With regard to chemoprevention, dietary antioxidants are considered to act as protective in colon carcinogenesis (5, 6) . Amongst the antioxidants, ascorbic acid (vitamin C) plays a central role as it contributes to the regeneration of vitamin E and constitutes a strong line of defence in retarding free radical induced cellular damage (7) . Ascorbic acid was shown to reduce the spontaneous mutation rate in mismatch-repair deficient human colon cancer cells and to reduce microsatellite instability (8) . Moreover, the DNA of lymphocytes from colorectal carcinoma patients contains a higher level of 8-oxo-2 H -deoxyguanosine, as a marker of base alterations by reactive oxygen species leading to mutations during replication of DNA, and that this was found to be associated with lowered plasma levels of antioxidant vitamins (9) . It was suggested therefore, that the decreased concentration of antioxidant vitamins might cause a pro-oxidative environment in blood cells of colorectal carcinoma patients (9) . With regard to later stages of the carcinogenesis process that are triggered, e.g. by mutations in cellEEcycle regulating proteins in the initiation phase, it is important to note that supplementation of vitamins C, A and E in patients with colorectal adenomas is effective in reducing abnormalities in cell kinetics that may be indicative of a pre-cancerous condition (10) . However, in a 3-year placebo-controlled endoscopic followup and intervention study against growth and recurrence of colonic polyps, supplementation of 150 mg ascorbic acid daily together with other antioxidant vitamins did not result in significant differences between the two groups (11) . Apoptosis is a crucial parameter in the carcinogenesis process as genetically damaged or mutated cells can be eliminated by apoptosis (12) . High vitamin C intake, however, was associated with reduced colorectal apoptosis rates among individuals with adenomas and it was suggested therefore, that vitamin C supplements might be contraindicated in patients with a history of adenomas (13) . In contrast, in an in vitro solid tumor model ascorbic acid displayed cytotoxic activities towards tumor cells and was suggested as an adjuvant cancer treatment (14) .
To assess whether ascorbic acid interferes with apoptotis execution in transformed cells, we investigated the impact of ascorbic acid on apoptosis when initiated by the classical antitumor drug camptothecin or the equally potent flavonoid flavone in HT-29 human colorectal cancer cells. By using a semi-quantitative RTEEPCR approach and western blotting we determined mRNA and protein levels of apoptosis-relevant gene products and by confocal microscopy we determined the role of oxygen radicals in the apoptotic response of the cells.
Materials and methods
Cell culture HT-29 cells (passage 106) were provided by American Type Culture Collection and used between passage 150 and 200. Cells were cultured and passaged in RPMI-1640 supplemented with 10% FCS and 2 mM glutamine. Antibiotics added to the media were 100 U/ml penicillin and 100 mg/ml streptomycin. The cultures were maintained in a humidified atmosphere of 95% air and 5% CO 2 at 37 C. Cells were passaged at pre-confluent densities by the use of a solution containing 0.05% trypsin and 0.5 mM EDTA (all materials for cell culture were from Invitrogen, Karlsruhe, Germany).
Preparation of stock solutions
Stock solutions of 100 mM l-ascorbic acid (Sigma, Diesenhofen, Germany) and 1 M mannitol (Roth, Karlsruhe, Germany) were prepared fresh in a modified Krebs buffer, containing 137 mM NaCl, 5.4 mM KCl, 2.8 mM CaCl 2 , 1 mM MgSO 4 , 0.3 mM NaH 2 PO 4 , 0.3 mM KH 2 PO 4 , 10 mM glucose and 10 mM HEPESEETris, pH 7.4. Dilutions of these stock solutions were made directly in cell culture media. Stock solutions of flavone (30 mM; Sigma), camptothecin (10 mM; Sigma) and p-benzoquinone (1 mM; Sigma) were prepared in DMSO. DMSO concentrations in the cell culture experiments did not exceed 1% and controls were always treated with the same amount of DMSO as used in the corresponding experiments.
Abbreviations: COX-2, cyclooxygenase-2; GAP-DH, glyceraldehyde-3-phosphate dehydrogenase; RTEEPCR, reverse transcriptaseEEpolymerase chain reaction. À , cells were loaded with 50 mM proxylfluorescamine (Bioprobes) for the last 2 h of incubation. 200 mM cysteine were added to the incubation media to yield an increase in the emission of proxylfluorescamine fluorescence due to the reduction of the fluorophore nitroxide to its corresponding hydroxylamine in the presence of superoxide (15) . O 2 À was detected after excitation with the UV-laser at emissions of 440EE480 nm and mitochondria were visualized after excitation at 543 nm at emissions of 590EE650 nm, respectively. The fluorescence ratios of proxylfluorescamine over MitoTracker were determined exclusively for the mitochondrial areas using the Leica Confocal Software, Version 2.5.
Detection of apoptosis
Caspase-3-like activity was measured as described previously (16), based on the method of Nicholson et al. (17) . In brief, HT-29 cells were seeded at a density of 5 Â 10 5 /well onto 6-well plates (Renner, Dannstadt, Germany) and allowed to adhere for 24 h. Cells were then exposed for 24 h to the test compounds. Subsequently to the exposure to the test compounds, cells were trypsinized, cell numbers were determined and then the cells were centrifuged at 2500 g for 10 min. Cytosolic extracts were prepared by adding 750 ml of a buffer containing 2 mM EDTA, 0.1% CHAPS, 5 mM dithiotreitol (DTT), 1 mM PMSF, 10 mg/ml pepstatin A, 20 mg/ml leupeptin, 10 mg/ml aprotinin and 10 mM HEPESEEKOH, pH 7.4, to each pellet and homogenizing by 10 strokes. The homogenate was centrifugated at 100 000 g at 4 C for 30 min and the cytosolic supernatant was incubated with the fluorogenic caspase-3 tetrapeptide-substrate Ac-DEVD-AMC (Calbiochem, Bad Soden, Germany) at a final concentration of 20 mM. Cleavage of the apopain substrate was followed by determination of emission at 460 nm after excitation at 390 nm using a fluorescence microtiter plate reader (Fluoroskan Ascent, Labsystems, Bornheim-Hersel, Germany).
Changes in membrane permeability, as another early apoptosis marker, were assessed by incubating 3 Â 10 4 HT-29 cells on 24-well plates (Renner) with the test compounds or cell culture medium alone (control) for 24 h. Cells were stained with 1 mg/ml Hoechst 33342 (Sigma) and rate of accumulation of the dye in early apoptotic cells (18) was detected using an inverted fluorescence microscope (Leica DMIRBE) equipped with a bandpass excitation filter of 340 EE380 nm and a longpass emission filter of 425 nm. Photographs were made from at least three independent cell batches and the number of apoptotic cells was determined as the percentage of the total cell count.
Nuclear fragmentation as a late marker of apoptosis was determined by staining of DNA with Hoechst 33258 (Sigma). HT-29 cells (3 Â 10 4 ) were incubated with the test compounds for the times indicated. Thereafter, cells were washed with PBS, allowed to air-dry for 30 min and then fixed with 2% paraformaldehyde prior to staining with 1 mg/ml Hoechst 33258 and visualization under the inverted fluorescence microscope. Photographs were made from at least three independent cell batches and apoptotic cells were determined according to the number of cells displaying chromatin condensation and nuclear fragmentation in comparison with total cell counts.
Semi-quantitative RTEEPCR
RNA from HT-29 cells was isolated at the times indicated according to the method described by Chomczynski and Sacchi (19) with slight modifications (16) . Reverse transcription was performed with 5 mg of isolated RNA. First strand cDNA synthesis was accomplished with an oligo-(dT) 15 primer (MBI Fermentas). Amplification of sequence-specific fragments (Taq polymerase was from Sigma) was performed with 30 cycles (95 C denaturation for 1 min, 55 C hybridization for 2 min, 72 C extensions for 2 min). RTEEPCR products were separated on a 1% agarose gel and visualized by ethidium bromide. The amount of first strand used to amplify specific sequences was derived from the linear range of amplification. The amplified glyceraldehyde-3-phosphate dehydrogenase (GAP-DH) sequence was used as a constitutively expressed control. The amplified products were photographed and the intensity of the bands was analyzed using the SigmaGel software. No products were obtained for all genes without reverse transcription indicating the specificity of mRNA determination. A l-DNA/EcoRI HindIII marker (MBI Fermentas) was used in all PCR experiments as a size control of the amplified products. Primers (Eurogentech) used were: GAP-DH ( Immunoblotting HT-29 cells were incubated in 6-well cell culture plates (Renner) with or without effectors for 24 h and scraped off in Laemmli equilibration buffer containing 50 mM Tris, 100 mM DTT, 10% glycerin, 2% SDS and 0.1% bromphenol blue. Samples were centrifuged at 2500 g for 5 min and protein content in the supernatant was determined by the Bradford reaction (Bio-Rad, Munich, Germany). The samples were resolved by SDSEEPAGE according to the method described by Schagger and von Jagow (20) and were electroblotted onto PVDF membranes (Roth). Control of protein transfer and identification of the molecular weight marker proteins was achieved by Ponceau Red staining. Thereafter, the blotting membranes were blocked for 1 h with TBST and then incubated with the primary antibody (anti-bcl-X L , anti-actin, sc-1615; Santa Cruz, Heidelberg, Germany) for 1 h in a 1:1000 dilution in TBST. Bound antibodies were detected after 1 h incubation with HRP-conjugated secondary reagents (sc-2020 for antiactin and sc-2004 for bcl-X L ; Santa Cruz) and 3-amino-9-ethylcarbazole and H 2 O 2 as substrates. The stained bands were analyzed using the SigmaGel sofware with the area under the curve of density serving as the measure of protein quantity.
Calculations and statistics
Variance analysis between groups was performed by one-way ANOVA and significance of differences between control and treated cells were determined by a Bonferroni's multiple comparison test (GraphPadPrism). For each variable at least three independent experiments were carried out. Data are given as the mean AE SEM.
Results
Ascorbic acid blocks camptothecin-and flavone-induced apoptosis Camptothecin and flavone were shown previously to stimulate caspase-3-like activity in HT-29 cells 6-and 7-fold, respectively, with a maximum of activation of~24 h (16) . These effects are achieved at concentrations of camptothecin and flavone of 50 and 150 mM, respectively, which represent the highest concentrations not causing any cytotoxic side effects (16) . When ascorbic acid was provided it reduced the caspase-3-like activity when increased by camptothecin or flavone in a dose-dependent manner with EC 50 -values for half maximal inhibition of 250.8 AE 11.4 mM and 189.4 AE 11.8 mM, respectively ( Figure 1) . Caspase-3-like activation by camptothecin and flavone was associated with the disintegration of the plasma membrane at 24 h of incubation ( Figure 2 ) and was followed by nuclear fragmentation after 48 h (Figure 3 ). Both processes were strongly inhibited by 1 mM ascorbic acid (Figures 2 and 3) . Ascorbic acid did not influence any of the apoptotic parameters measured when applied alone (Figures 2 and 3) .
Ascorbic acid scavenges mitochondrial O 2

À
We have shown previously that nitric oxide (NO) scavenges mitochondrial O 2 À and thereby prevents the downregulation of bcl-X L that is crucial for the occurrence of apoptosis in HT-29 cells (21) . To investigate whether ascorbic acid blocks apoptosis also by its antioxidative capacity, we measured its influence on the camptothecin-and flavone-induced reductions caused by camptothecin or flavone ( Figure 5 ). Moreover, this blockade of bcl-X L down-regulation by ascorbic acid was specific, since the levels of other apoptosis-relevant genes, such as Bax, Bak, p21 or COX-2 were altered by camptothecin and flavone but those alterations remained unaffected by ascorbic acid (Table I ). The transcript levels of NF-kB were reduced by camptothecin and flavone and this reduction was inhibited by the addition of ascorbic acid, although the inhibition did not reach the level of significance here (Table I) . Changes in c-myc mRNA levels, however, were completely prevented in cells exposed to camptothecin and flavone when ascorbic acid was present Ascorbic acid suppresses drug-induced apoptosis (Table I) . Since flavone-induced apoptosis is observed already at 24 h of incubation (Figures 2 and 3 ) whereas c-myc mRNA levels are reduced no earlier than 48 h, we conclude that c-myc most likely does not contribute to apoptosis initiation by flavone or its inhibition by ascorbic acid. (23) . p-Benzoquinone prevented the generation of proxylfluorescamine fluorescence in mitochondria of both, camptothecin-or flavone-treated HT-29 cells, whereas mannitol was without effect ( Figure 6A ). Moreover, p-benzoquinone but not mannitol also prevented the disappearance of the bcl-X L protein ( Figure 6B ) that was observed when cells were exposed to camptothecin or flavone alone ( Figure 5B ). The data strongly suggest that O 2 À but not OH are the reactive oxygen species that regulate the expression of bcl-X L . Finally, p-benzoquinone blocked camptothecin-or flavone-induced apoptosis as potently as ascorbic acid, whereas mannitol was without any effect ( Figure 7 ).
Discussion
To understand why tumor cells resist apoptosis in response to the death signals has become a central theme in the understanding of tumor development (24) and one of the major goals Transcript levels are given as the ratios of band intensities (AUC) of amplified cDNAs from target genes versus GAP-DH (used as a constitutively expressed control). Prior to semi-quantitative RTEEPCR cells were treated with medium alone (control), with 1 mM ascorbic acid or with 150 mM flavone, 50 mM camptothecin (campto), 150 mM flavone and 1 mM ascorbic acid (flavone/ascorbic acid) or 50 mM camptothecin and 1 mM ascorbic acid (campto/ascorbic acid) for the indicated times. in cancer therapy is to restore the sensitivity of transformed cells towards apoptotic signals and to allow the execution of apoptotic cell death (25, 26) . Whereas antioxidants are in particular regarded as effective chemopreventive agents due to their potent scavenging activities of reactive oxygen species (9), their role in later stages of the transformation process is not that clear. Reactive oxygen species may be essential as activators of apoptosis to remove cells that have accumulated mutations (27EE29) and it was demonstrated that depletion of antioxidants is able to inhibit tumor growth in a transgenic mouse brain tumor model (30). Moreover, anti-apoptotic proteins that act as antioxidants, such as certain members of the bcl-2 family, are usually up regulated in cancer cells as a mechanism to escape apoptosis (31EE33).
In the present study we have investigated the impact of ascorbic acid as a prototype antioxidant and essential micronutrient in human nutrition on apoptosis in HT-29 human colorectal carcinoma cells when initiated either by the classical antitumor drug camptothecin or by the flavonoid flavone. HT-29 cells in this regard serve here as a model for a colonic cancer tissue carrying all the genetic alterations acquired during the early stages of colorectal tumorigenesis (34) with expression of the truncated APC protein (35) , as well as all alterations occurring in later stages with loss-of-function mutations in the tumor suppressor gene p53 (36) . We show here that ascorbic acid reduced the activity of the apoptosis effector caspase-3 dose-dependently with half maximal inhibitor concentrations of~250 mM for camptothecin-and 190 mM for flavone-induced caspase-3 activation. In addition to caspase-3 activation, two further indicators of apoptosis occurrence, membrane disintegration and nuclear fragmentation, were highly increased by camptothecin and flavone and were effectively inhibited when 1 mM ascorbic acid was provided additionally. The concentrations at which ascorbic acid exerted its pronounced effects are found in normal human cells, such as brain cells (37) or circulating blood cells (38) . We have shown previously that nitric oxide also prevents apoptosis in HT-29 cells by scavenging mitochondrial O 2 À and thereby inhibits the flavone-mediated reduction in the levels of anti-apoptotic bcl-X L and the subsequent depolarization of the mitochondrial membrane potential with the release of cytochrome c from mitochondria and finally the activation of caspase-3 (21). These results suggested that ascorbic acid by its radical scavenging activity could act via a similar or even identical mechanism to block apoptosis in HT-29 cells. Indeed ascorbic acid was able to potently reduce O 2 À in mitochondria of cells treated with camptothecin or flavone. We did not see such a potent reduction of O 2 À in mitochondria of camptothecin-treated cells by nitric oxide in our previous studies (21) , suggesting that ascorbic acid possesses a higher antioxidative potential. Moreover, the ability of camptothecin (39) but not of flavone (40) to release reactive oxygen species, independent on mitochondrial O 2 À generation, might explain the higher EC 50 values found for inhibition of camptothecin-induced caspase-3 activation versus flavone-induced increase in caspase-3-like activity. 
Ascorbic acid suppresses drug-induced apoptosis
The expression of the mitochondrial anti-apoptotic protein bcl-X L was shown to be sensitive to reactive oxygen species (41) and we have shown previously that its down-regulation is crucial for the occurrence of apoptosis in transformed and nontransformed human colonocytes (21, 42) . Here we show that ascorbic acid prevents the decrease in bcl-X L levels upon camptothecin and flavone treatment at the mRNA level as well as at the protein level. The effects of ascorbic acid on bcl-X L expression and on apoptosis were mimicked by p-benzoquinone, a O 2 À scavenger, whereas the OH scavenger mannitol did not alter bcl-X L expression nor apoptosis. The data suggest strongly that O 2 À are the reactive oxygen species that regulate bcl-X L expression and apoptosis in HT-29 cells. Other apoptosis-relevant genes such as Bax, Bak, p21, COX-2 and NF-kB also displayed altered transcript levels after camptothecin and flavone treatment of cells but ascorbic acid failed to affect their changes. The observed down-regulation of NF-kB by camptothecin and flavone was also inhibited by ascorbic acid although this did not reach statistical significance. In this context, it is interesting to add that nitric oxide was shown to reduce mitochondrial O 2 À generation in flavonetreated HT-29 cells and to block the flavone-mediated reduction in NF-kB mRNA levels (21) . Our data presented here consequently provide additional evidence that NF-kB transcript levels are regulated by O 2 À . However, a clear difference was observed between the effects of NO and ascorbic acid on gene expression of Bak. In the presence of nitric oxide, bak mRNA levels declined in flavone-treated cells below that in control cells (21) , whereas ascorbic acid reduced the flavonemediated increase in bak transcript-levels at 48 h of incubation only modestly. This indicates, that besides their common action of scavenging reactive oxygen species, NO and ascorbic acid also alter gene expression selectively.
In conclusion, our studies provide evidence that ascorbic acid by its antioxidative capacity reduces drastically the production of reactive oxygen species in mitochondria that are required for the execution of drug-induced apoptosis. The data consequently raise the question of whether a high intake of ascorbic acid during chemotherapy of tumors is beneficial.
